Enterprise Value
800.6M
Cash
298.5M
Avg Qtr Burn
-33.33M
Short % of Float
36.80%
Insider Ownership
8.66%
Institutional Own.
-
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
XDEMVY (TP-03) Details Eye disease , Demodex Blepharitis | Approved Quarterly sales | |
TP-03 Details Meibomian Gland Disease , Demodex Blepharitis | Phase 3 Update | |
TP-03 Details Meibomian Gland Disease | Phase 2a Update | |
TP-05 Details Lyme disease | Phase 2a Update | |
TP-04 Details Papulopustular rosacea | Phase 2a Update |